Read More Pharma Industry News GNI Group to halt enrolment in Phase 2 liver fibrosis trial following positive results Japanese biotech company GNI Group has announced it will cease enrolment of new patients in its Phase 2… bypharmanewsdailyOctober 2, 2018
